Clinical Trial Update: Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy

View source ↗

Summary

A Mayo Clinic study evaluating neuroendocrine differentiation as a potential mechanism of prostate cancer recurrence after radiotherapy; the trial is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Prostate Cancer | Status: ACTIVE_NOT_RECRUITING